PTGX Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Protagonist Therapeutics Inc (PTGX) Moving Averages Convergence Divergence (MACD) indicator is -0.133, suggesting PTGX is Strong Sell.

Protagonist Therapeutics Inc (PTGX) 20-Day simple moving average is 100.884, while Protagonist Therapeutics Inc (PTGX) share price is $99.56, making it Sell.

Protagonist Therapeutics Inc (PTGX) 60-Day simple moving average is 100.562, while Protagonist Therapeutics Inc (PTGX) share price is $99.56, making it Sell.

Technical Analysis for PTGX

Technical Sentiment Analysis for Protagonist Therapeutics Inc (PTGX) As of 2026-05-29, Protagonist Therapeutics Inc (PTGX) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 12 technical signals, shows that 2 indicators are flashing buy, while 10 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for PTGX stands at 47.627, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.133, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 44.691 and the Commodity Channel Index (CCI) at -28.857 further confirm a -5.99 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, PTGX is trading above its 60-day moving average of $100.562 and above its 200-day long-term moving average of $84.202. Key price levels to watch include the immediate resistance at $104.398 and strong support at $96.7. A break above $104.398 could signal a bull continuation, while falling below $96.7 may test the next Fibonacci floor at $92.847.

Protagonist Therapeutics Inc (PTGX) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	89.002	92.847	96.7	100.545	104.398	108.243	112.096
Fibonacci	92.847	95.788	97.604	100.545	103.486	105.302	108.243

Protagonist Therapeutics Inc (PTGX) Technical Indicators

2026-05-29

Name	Value
RSI_14	47.627
STOCHk_14_3_3	44.691
STOCHd_14_3_3	44.223
CCI_20	-28.857
AO_5_34	-0.899
MOM_10	-5.99
MACD_12_26_9	-0.133

Protagonist Therapeutics Inc (PTGX) Relative Strength Index (RSI) is 47.627, creating a Neutral signal.

Protagonist Therapeutics Inc (PTGX) Stochastic Oscillator is 44.691, creating a Neutral signal.

Protagonist Therapeutics Inc (PTGX) Stochastic RSI is 44.223, creating a Neutral signal.

Protagonist Therapeutics Inc (PTGX) Commodity Channel Index (CCI) is -28.857, creating a Neutral signal.

Protagonist Therapeutics Inc (PTGX) Awesome Oscillator is -0.899, creating a Sell signal.

Protagonist Therapeutics Inc (PTGX) Momentum is -5.99, creating a Sell signal.

Protagonist Therapeutics Inc (PTGX) MACD is -0.133, creating a Sell signal.

Protagonist Therapeutics Inc (PTGX) Moving Average

2026-05-29

Period	Simple	Signal
MA_5	100.27	Sell
MA_10	100.553	Sell
MA_20	100.884	Sell
MA_60	100.562	Sell
MA_200	84.202	Buy
MA_250	78.135	Buy

Protagonist Therapeutics Inc (PTGX) 5-Day simple moving average is 100.27, while Protagonist Therapeutics Inc (PTGX) share price is $99.56, making it a Sell.

Protagonist Therapeutics Inc (PTGX) 10-Day simple moving average is 100.553, while Protagonist Therapeutics Inc (PTGX) share price is $99.56, making it a Sell.

Protagonist Therapeutics Inc (PTGX) 20-Day simple moving average is 100.884, while Protagonist Therapeutics Inc (PTGX) share price is $99.56, making it a Sell.

Protagonist Therapeutics Inc (PTGX) 60-Day simple moving average is 100.562, while Protagonist Therapeutics Inc (PTGX) share price is $99.56, making it a Sell.

Protagonist Therapeutics Inc (PTGX) 200-Day simple moving average is 84.202, while Protagonist Therapeutics Inc (PTGX) share price is $99.56, making it a Buy.

Protagonist Therapeutics Inc (PTGX) 250-Day simple moving average is 78.135, while Protagonist Therapeutics Inc (PTGX) share price is $99.56, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for PTGX?

The overall technical consensus for Protagonist Therapeutics Inc (PTGX) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 0 buy signals and 6 sell signals.

What are the key support and resistance levels for Protagonist Therapeutics Inc (PTGX) today?

Based on pivot point calculations, Protagonist Therapeutics Inc (PTGX) has an immediate support level at 96.7 and a major resistance level at 104.398. Traders also monitor the pivot point at 100.545 to determine the intraday trend direction.

Is Protagonist Therapeutics Inc (PTGX) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Protagonist Therapeutics Inc (PTGX) is currently 47.627. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Protagonist Therapeutics Inc (PTGX)?

Protagonist Therapeutics Inc (PTGX) Moving Averages Convergence Divergence (MACD) indicator is -0.133, suggesting PTGX is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Protagonist Therapeutics Inc.

How is Protagonist Therapeutics Inc (PTGX) performing relative to its 200-day moving average?

Protagonist Therapeutics Inc (PTGX) is currently trading at $99.56, which is above its 200-day simple moving average of 84.202. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.